Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of Belgian IBD Research and Development is < 0.1% (very low). The company has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
20 mandates
11
active directors
ARIJS IngridDirectorCREMER AnnelineDirectorREENAERS CatherineDirector+17 in history
All directors & mandates Publicationslatest 27-10-2025
16
publications in the State Gazette7 directors appointed, 1 resigningAll publications & acts Network & structure
11
connected companiesSee network & structure
Connections
11 connected companiesTrust signals
3 signalsLong-established
Founded in 1998 — 28 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone< 0.1%
Very low
0%0,5%1,5%4%10%≥25%
Lower-risk legal form
−Lower-failure-rate sector
−Long track record
−
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Activiteiten van medische laboratoria86901Overige menselijke gezondheidszorg, n.e.g.86909Activiteiten van medische beeldvorming en medische laboratoria86910Activiteiten op het gebied van voeding86995
Primary activity highlighted.
Names & trade names
| Legal nameFR | Belgian IBD Research and Development |
| Legal nameNL | Belgian IBD Research and Development |
| AbbreviationFR | BIRD |
Registered office
Leuvensesteenweg 643
1930 Zaventem, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.